Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 3180 to 3229 of 7460 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1088\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pxr2b protein. [source:refseq;acc:nm\_016559]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.945\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 207.109\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.836\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1089\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent atpase, h+ transporting, lysosomal 38kda, v0 subunit d isoform 2. [source:refseq;acc:nm\_152565]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 218.487\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.656\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.831\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent cleavage stimulation factor subunit 3; cleavage stimulation factor, 3' pre-rna, subunit 3, 77kd. [source:refseq;acc:nm\_001326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 121.428\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 125.004\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02945\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1090\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent neurocalcin delta. [source:swissprot;acc:p29554]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 225.104\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 230.931\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.827\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent similar to ribosomal protein, large, p0. [source:sptrembl;acc:q96fq9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 226.218\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 232.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02945\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1091\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent block 23. [source:sptrembl;acc:q8nhw5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 226.205\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 232.858\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02941\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent neuron specific calcium-binding protein hippocalcin (p23k) (calcium- binding protein bdr-2). [source:swissprot;acc:p32076]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 225.103\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 230.928\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.825\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1092\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s acidic ribosomal protein p0 (l10e). [source:swissprot;acc:p05388]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 226.203\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 232.855\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02941\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent visinin-like protein 3 (vilip-3) (calcium-binding protein bdr-1) (hlp2) (hippocalcin-like protein 1). [source:swissprot;acc:p37235]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 225.094\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 230.913\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.819\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1093\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent coatomer alpha subunit (alpha-coat protein) (alpha-cop) (hepcop) (hep-cop) [contains: xenin (xenopsin-related peptide); proxenin]. [source:swissprot;acc:p53621]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 177.432\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 182.647\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02939\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase subunit g 2 (ec 3.6.3.14) (v-atpase g subunit 2) (vacuolar proton pump g subunit 2) (v-atpase 13 kda subunit 2). [source:swissprot;acc:o95670]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.809\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1094\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent annexin a7 (annexin vii) (synexin). [source:swissprot;acc:p20073]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 219.655\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.385\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02938\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent apoptosis inhibitor 5; fibroblast growth factor 2-interacting factor 2; api5-like 1. [source:refseq;acc:nm\_006595]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.809\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1095\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial gtp binding protein isoform v. [source:refseq;acc:nm\_032620]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.552\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 207.463\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02935\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sec13-related protein. [source:swissprot;acc:p55735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.809\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1096\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase b22 subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b22) (ci-b22). [source:swissprot;acc:q9y6m9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.345\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 206.339\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02911\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase subunit g 3 (ec 3.6.3.14) (v-atpase g subunit 3) (vacuolar proton pump g subunit 3) (v-atpase 13 kda subunit 3). [source:swissprot;acc:q96lb4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.809\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1097\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent probable calcium-transporting atpase kiaa0703 (ec 3.6.3.8). [source:swissprot;acc:o75185]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 209.123\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.208\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02911\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase subunit b, brain isoform (ec 3.6.3.14) (v-atpase b2 subunit) (vacuolar proton pump b isoform 2) (endomembrane proton pump 58 kda subunit) (ho57). [source:swissprot;acc:p21281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.809\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1098\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent adapter-related protein complex 3 mu 1 subunit (mu-adaptin 3a) (ap-3 adapter complex mu3a subunit). [source:swissprot;acc:q9y2t2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.323\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02906\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent yeast sec31p homolog. [source:refseq;acc:nm\_014933]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.809\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1099\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent adapter-related protein complex 3 mu 2 subunit (clathrin coat assembly protein ap47 homolog 2) (clathrin coat associated protein ap47 homolog 2) (golgi adaptor ap-1 47 kda protein homolog 2) (ha1 47 kda subunit homolog 2) (clathrin assembly protein assembly protein complex 1 medium chain homolog 2) (p47b). [source:swissprot;acc:p53677]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.315\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.183\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02904\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase subunit g 1 (ec 3.6.3.14) (v-atpase g subunit 1) (vacuolar proton pump g subunit 1) (v-atpase 13 kda subunit 1) (vacuolar atp synthase subunit m16). [source:swissprot;acc:o75348]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.809\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1100\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent calcium-transporting atpase type 2c, member 1 (ec 3.6.3.8) (atpase 2c1) (atp-dependent ca(2+) pump pmr1) (hussy-28). [source:swissprot;acc:p98194]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 209.052\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.183\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02889\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase subunit e (ec 3.6.3.14) (v-atpase e subunit) (vacuolar proton pump e subunit) (v-atpase 31 kda subunit) (p31). [source:swissprot;acc:p36543]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 218.484\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 5.809\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1101\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ganglioside-induced differentiation-associated protein 1-like 1. [source:refseq;acc:nm\_024034]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent lysyl-trna synthetase (ec 6.1.1.6) (lysine--trna ligase) (lysrs). [source:swissprot;acc:q15046]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 220.291\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 226.584\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02857\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1102\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 40s ribosomal protein s27 (metallopan-stimulin 1) (mps-1). [source:swissprot;acc:p42677]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 229.442\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 235.974\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02847\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent dead (asp-glu-ala-asp) box polypeptide 39 isoform 1; nuclear rna helicase, decd variant of dead box family. [source:refseq;acc:nm\_005804]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 218.484\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 5.809\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1103\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ganglioside-induced differentiation-associated protein 1. [source:refseq;acc:nm\_018972]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ribosomal protein s27-like protein; 40s ribosomal protein s27 isoform. [source:refseq;acc:nm\_015920]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.441\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 235.972\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02846\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1104\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent hydroxyacid oxidase 1 (ec 1.1.3.15) (haox1) (glycolate oxidase) (gox). [source:swissprot;acc:q9ujm8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 231.922\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 238.486\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0283\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase 28 kda accessory protein). [source:swissprot;acc:q9y5k8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.809\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1105\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent adrenodoxin, mitochondrial precursor (adrenal ferredoxin) (hepatoredoxin) (ferredoxin 1). [source:swissprot;acc:p10109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 191.139\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 185.882\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02828\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent secretory pathway component sec31b-1. [source:refseq;acc:nm\_015490]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.809\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1106\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent pxr2b protein. [source:refseq;acc:nm\_016559]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.945\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 207.109\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02818\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase subunit h (ec 3.6.3.14) (v-atpase h subunit) (vacuolar proton pump h subunit) (v-atpase 50/57 kda subunits) (vacuolar proton pump subunit sfd) (cgi-11). [source:swissprot;acc:q9ui12]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.809\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1107\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent serine palmitoyltransferase 2 (ec 2.3.1.50) (long chain base biosynthesis protein 2) (lcb 2) (serine-palmitoyl-coa transferase 2) (spt 2). [source:swissprot;acc:o15270]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.603\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 210.324\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02796\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase subunit b, kidney isoform (ec 3.6.3.14) (v- atpase b1 subunit) (vacuolar proton pump b isoform 1) (endomembrane proton pump 58 kda subunit). [source:swissprot;acc:p15313]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.483\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.676\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.807\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1108\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent interleukin enhancer-binding factor 1 (cellular transcription factor ilf-1). [source:swissprot;acc:q01167]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.006\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.119\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02775\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase subunit f (ec 3.6.3.14) (v-atpase f subunit) (vacuolar proton pump f subunit) (v-atpase 14 kda subunit). [source:swissprot;acc:q16864]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.481\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.806\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1109\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent epidermal growth factor receptor pathway substrate 8-like protein 1 isoform c; epidermal growth factor receptor pathway substrate 8-related protein 1; eps8-related protein 1. [source:refseq;acc:nm\_139204]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 221.939\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 216.143\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.796\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent translationally controlled tumor protein (tctp) (p23) (histamine- releasing factor) (hrf). [source:swissprot;acc:p13693]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.098\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.209\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02775\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1110\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent arf gtpase-activating protein git2 (g protein-coupled receptor kinase- interactor 2). [source:swissprot;acc:q14161]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 216.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 222.782\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02769\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ba305p22.3 (breast carcinoma amplified sequence 4). [source:sptrembl;acc:q8ndy6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 159.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 164.917\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.787\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1111\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.123\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02766\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent basic helix-loop-helix domain containing, class b, 5; trinucleotide repeat containing 20. [source:refseq;acc:nm\_152414]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 159.165\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 164.951\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.786\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1112\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent epidermal growth factor receptor kinase substrate eps8. [source:swissprot;acc:q12929]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 221.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 216.146\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.784\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent hepatocyte nuclear factor 4-gamma (hnf-4-gamma). [source:swissprot;acc:q14541]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 251.863\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 258.829\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.02766\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1113\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent growth arrest and dna-damage-inducible protein gadd45 gamma (cytokine responsive protein cr6). [source:swissprot;acc:o95257]\vspace{3pt}}&&&&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/